Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)

v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenues $ 7,174 $ 5,604 $ 13,580 $ 9,619
Cost of revenues 4,367 3,484 8,196 6,035
Gross profit 2,807 2,120 5,384 3,584
Operating expenses:        
Research and development 469 575 1,066 1,169
Selling, general and administrative 2,048 1,882 4,068 3,847
Total operating expenses 2,517 2,457 5,134 5,016
Income (loss) from operations 290 (337) 250 (1,432)
Other income (expense), net 92 (394) (198) (541)
Net income (loss) before income taxes 382 (731) 52 (1,973)
Income tax (expense) benefit (448) 197 (448) 198
Net loss $ (66) $ (534) $ (396) $ (1,775)
Net loss per share: basic $ (0.01) $ (0.32) $ (0.09) $ (1.08)
Net loss per share: diluted $ (0.01) $ (0.32) $ (0.09) $ (1.08)
Weighted-average shares outstanding: basic 4,909 1,646 4,381 1,643
Weighted-average shares outstanding: diluted 4,909 1,646 4,381 1,643
Other comprehensive loss:        
Net loss $ (66) $ (534) $ (396) $ (1,775)
Foreign currency translation adjustments (324) 205 (89) 1,011
Comprehensive loss $ (390) $ (329) $ (485) $ (764)